Macrophage-tumor cell interaction promotes ATRT progression and chemoresistance

Acta Neuropathol. 2020 May;139(5):913-936. doi: 10.1007/s00401-019-02116-7. Epub 2019 Dec 17.

Abstract

Atypical teratoid/rhabdoid tumors (ATRT) are known for their heterogeneity concerning pathophysiology and outcome. However, predictive factors within distinct subgroups still need to be uncovered. Using multiplex immunofluorescent staining and single-cell RNA sequencing we unraveled distinct compositions of the immunological tumor microenvironment (TME) across ATRT subgroups. CD68+ cells predominantly infiltrate ATRT-SHH and ATRT-MYC and are a negative prognostic factor for patients' survival. Within the murine ATRT-MYC and ATRT-SHH TME, Cd68+ macrophages are core to intercellular communication with tumor cells. In ATRT-MYC distinct tumor cell phenotypes express macrophage marker genes. These cells are involved in the acquisition of chemotherapy resistance in our relapse xenograft mouse model. In conclusion, the tumor cell-macrophage interaction contributes to ATRT-MYC heterogeneity and potentially to tumor recurrence.

Keywords: Atypical teratoid/rhabdoid tumor; Cell interaction; Chemotherapy resistance; Single-cell RNA sequencing; Tumor microenvironment; Tumor-associated macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism
  • Central Nervous System Neoplasms / metabolism
  • Central Nervous System Neoplasms / pathology
  • Drug Resistance, Neoplasm / physiology*
  • Female
  • Humans
  • Macrophages / pathology*
  • Male
  • Mice, Transgenic
  • Neoplasm Recurrence, Local / pathology*
  • Rhabdoid Tumor / genetics
  • Tumor Microenvironment / physiology*

Substances

  • Biomarkers, Tumor